Barnaby Balmforth
Vorstandsvorsitzender bei Biofidelity Ltd.
Aktive Positionen von Barnaby Balmforth
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Biofidelity Ltd.
 Biofidelity Ltd. Miscellaneous Commercial ServicesCommercial Services Biofidelity Ltd. engages in research and experimental development on biotechnology. The company was founded by Barnaby Balmforth and Cameron Frayling on February 15, 2019 and is headquartered in Cambridge, the United Kingdom. | Vorstandsvorsitzender | 15.02.2019 | - |
| Gründer | 15.02.2019 | - |
Karriereverlauf von Barnaby Balmforth
Ehemalige bekannte Positionen von Barnaby Balmforth
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Base4 Innovation Ltd.
 Base4 Innovation Ltd. Medical SpecialtiesHealth Technology Base4 Innovation Ltd. develops single molecule detection platforms for healthcare and life sciences. The firm develops DNA sequencing using techniques based on silicon chip technology which can easily be scaled up and this high-throughput technology will cut the time and cost of genetic tests, enabling them to be used much more in patient diagnosis and treatment. The company was founded by Cameron Alexander Frayling in 2007 and is headquartered in Cambridge, the United Kingdom. | Geschäftsführer | 01.01.2009 | - |
Ausbildung von Barnaby Balmforth
| University of Oxford | Undergraduate Degree |
| University of Cambridge | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 5 |
Operativ
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Base4 Innovation Ltd.
Base4 Innovation Ltd. Medical SpecialtiesHealth Technology Base4 Innovation Ltd. develops single molecule detection platforms for healthcare and life sciences. The firm develops DNA sequencing using techniques based on silicon chip technology which can easily be scaled up and this high-throughput technology will cut the time and cost of genetic tests, enabling them to be used much more in patient diagnosis and treatment. The company was founded by Cameron Alexander Frayling in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Biofidelity Ltd.
Biofidelity Ltd. Miscellaneous Commercial ServicesCommercial Services Biofidelity Ltd. engages in research and experimental development on biotechnology. The company was founded by Barnaby Balmforth and Cameron Frayling on February 15, 2019 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
- Börse
- Insiders
- Barnaby Balmforth
- Erfahrung
